IMDX
Insight Molecular Diagnostics
IMDX
IMDX
66 hedge funds and large institutions have $63.5M invested in Insight Molecular Diagnostics in 2020 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 28 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
6% less capital invested
Capital invested by funds: $67.8M → $63.5M (-$4.29M)
Holders
66
Holding in Top 10
2
Calls
$1K
Puts
$1K
Top Buyers
| 1 | +$5.7M | |
| 2 | +$2.01M | |
| 3 | +$1.97M | |
| 4 |
PVI
Pura Vida Investments
New York
|
+$774K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$748K |
Top Sellers
| 1 | -$4.99M | |
| 2 | -$287K | |
| 3 | -$143K | |
| 4 |
Barclays
London,
United Kingdom
|
-$103K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$96.9K |